NextCure (NXTC) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

NextCure Revenue Highlights


00

NextCure Revenue by Period


NextCure Revenue by Year

DateRevenueChange
2024-12-31-100.00%
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--100.00%
2020-12-31$22.38M252.58%
2019-12-31$6.35M100.00%
2018-12-31-100.00%
2017-12-31--

NextCure generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

NextCure Revenue by Quarter

DateRevenueChange
2025-06-30-100.00%
2025-03-31--100.00%
2024-12-31$3.28M100.00%
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$6.28M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30--100.00%
2020-03-31$22.38M1016.11%
2019-12-31$2.00M26.66%
2019-09-30$1.58M12.91%
2019-06-30$1.40M3.32%
2019-03-31$1.36M100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

NextCure generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

NextCure Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
VRCAVerrica Pharmaceuticals$7.57M$14.34M
PLURPluri$1.34M$427.00K
QTTBQ32 Bio$1.16M-
ANTXAN2 Therapeutics--
ITRMIterum Therapeutics-$390.00K
BOLDBoundless Bio--
INTSIntensity Therapeutics--
NXTCNextCure--
JSPRJasper Therapeutics--
PSTVPlus Therapeutics--
TAOXTAO Synergies--

NXTC Revenue FAQ


What is NextCure’s yearly revenue?

NextCure's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. NXTC's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is NextCure’s quarterly revenue?

NextCure's quarterly revenue for Q2 2025 was $0, a 100.00% increase from the previous quarter (Q1 2025), and a 0% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $0, a -100.00% decrease from the previous quarter (Q4 2024), and a 0% increase year-over-year (Q1 2024). NXTC's quarterly revenue for Q4 2024 was $3.28M, a 100.00% increase from the previous quarter (Q3 2024), and a -47.77% decrease year-over-year (Q4 2023).

What is NextCure’s revenue growth rate?

NextCure's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was -100.00%.